Distilled Insider — May 25, 2026

Insider Signal Report — 2026-05-25

Scan covers trade_date 2026-05-202026-05-25 | 13 qualifying trades scanned | 2 signals detected


★★★★★ Conviction Bottom

Criteria: C-Suite ≥$1M + Prior 30d −10% to −20%

C-suite executive (CEO/CFO/COO/CTO/President/Chairman) buying ≥$1M after the stock declined 10–20% in the prior 30 calendar days. Most robust combined signal in the dataset: ~58–63% win rate, EV +35–40% at 12–15m. Near-term pain is expected — must hold full 12 months.

Target Hold: 12–15 months

TickerCompanyTrade DateInsiderTitleValuePrior 30dC-SuiteNew PosAlso Qualifies
NCLHNorwegian Cruise Line Holdings Ltd.2026-05-22CHIDSEY JOHNPresident and CEO$2.5M-14.3%S3

★★★★ Informed Accumulation

Criteria: Repeat Buyer + Prior 30d −10% to −20%

Insider with a prior purchase in the same ticker within 2 years, adding to position after a 10–20% pullback. Deep institutional knowledge + deliberate price discipline. EV ~20–30%+ at 12–15m. Cross-check business quality — serial buyers into structural decline are noise.

Target Hold: 12–15 months

TickerCompanyTrade DateInsiderTitleValuePrior 30dC-SuiteNew PosAlso Qualifies
MPMP Materials Corp. / DE2026-05-20Rosenthal Michael StuartChief Operating Officer$963K-14.7%

Notable Buys — No Strategy Match

Trades ≥$500,000 that didn't meet any strategy filter. Often in the −5% to 0% prior-return zone (weakest bucket) or missing price data.

TickerCompanyTrade DateInsiderTitleValuePrior 30dC-SuiteNew PosAlso Qualifies
FBINFortune Brands Innovations, Inc.2026-05-20GARDEN EDWARD Pmaybe director$2.2M-15.4%
AATAmerican Assets Trust, Inc.2026-05-20RADY ERNEST SExecutive Chairman$1.6M+4.5%
MELIMERCADOLIBRE INC2026-05-22Aguzin Alejandro Nicolasmaybe director$994K-10.6%
GEHCGE HealthCare Technologies Inc.2026-05-22Lobo Kevinmaybe director$642K-10.0%

Signal Summary

RatingStrategySignals
★★★★★Conviction Bottom1
★★★★Informed Accumulation1
★★★★Fresh Conviction Entry0
★★★Momentum Confirmation0
★★Fallen Knife w/ Insider Backstop0

Generated 2026-05-25 · Strategies based on backtests 2021–2026 on US insider purchases

This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.